Purisys

Purisys is a global leader in custom synthesis of active pharmaceutical ingredients. We support pharma & biotech companies with APIs, reference standards, controlled substances, cannabinoids, psychedelics, and cGMP clinical & niche commercial CDMO services. Formed as a spin-off from Noramco in 2019, Purisys began manufacturing in 1979 as part of Johnson & Johnson. WORLD LEADER IN PHARMACEUTICAL CANNABINOIDS, PSYCHEDELICS & REFERENCE STANDARDS Purisys produces 50+ major and minor cannabinoids, as well as degradants, metabolites & analytical standards to support our customers in this growing field. In addition, we have DEA licenses for several Psychedelic basic classes and have produced GMP...

Bio/pharma cdmo,clinical/commercial apis,drug development,orphan drug,cannabinoids,reference standards,analytical chemistry,process chemistry,contract manufacturing,clinical & pre-clinical synthesis,solid state chemistry,controlled substances,parenterals,labile molecules,high potency (hpapi),custom synthesis,and structure elucidation

Purisys operates in the Pharmaceutical manufacturing industry.

Purisys's revenue is 11m - 100m

Purisys has 11 - 50 employees.